← back to search

Walter L. Eckalbar

University of California, San Francisco · US
Area of research
Infectious Diseases · Cancer Research
Research interest
Research interests include COVID-19 Clinical Research Studies, MicroRNA in disease regulation, Developmental Biology and Gene Regulation, and Long-Term Effects of COVID-19.
h-index
34
citations
4,184
works
149
NIH funding
primary concept
email

Recent publications

Meningeal regulatory T cells inhibit nociception in female mice
Science 2025cited by 29position: middledoi
Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis
Journal of Clinical Investigation 2025cited by 10position: middledoi
A multiomics recovery factor predicts long COVID in the IMPACC study
Journal of Clinical Investigation 2025cited by 3position: middledoi
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
Journal of Allergy and Clinical Immunology Global 2025cited by 1position: middledoi
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
JCI Insight 2025cited by 1position: middledoi
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality
medRxiv 2025cited by 0position: middledoi
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Frontiers in Medicine 2025cited by 0position: middledoi
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality
JCI Insight 2025cited by 0position: middledoi
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Nature Communications 2024cited by 57position: middledoi
Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis
Nature Communications 2024cited by 53position: middledoi
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
Journal of Clinical Investigation 2024cited by 32position: middledoi
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Science Translational Medicine 2024cited by 24position: middledoi
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19
Nature Communications 2024cited by 17position: middledoi
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 15position: middledoi
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 5position: middledoi
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
American Journal of Respiratory Cell and Molecular Biology 2022cited by 52position: middledoi
Bile acid–sensitive tuft cells regulate biliary neutrophil influx
Science Immunology 2022cited by 48position: middledoi
Global absence and targeting of protective immune states in severe COVID-19
Nature 2021cited by 275position: middledoi
Discovering dominant tumor immune archetypes in a pan-cancer census
Cell 2021cited by 171position: middledoi
CCR2 deficiency alters activation of microglia subsets in traumatic brain injury
Cell Reports 2021cited by 78position: middledoi
Molecular programs of fibrotic change in aging human lung
Nature Communications 2021cited by 75position: middledoi
Cbl-b deficiency prevents functional but not phenotypic T cell anergy
The Journal of Experimental Medicine 2021cited by 23position: middledoi
A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome
The Journal of Experimental Medicine 2020cited by 189position: middledoi
On the cross-population generalizability of gene expression prediction models
PLoS Genetics 2020cited by 83position: middledoi
Flow-Cytometric Analysis and Purification of Airway Epithelial-Cell Subsets
American Journal of Respiratory Cell and Molecular Biology 2020cited by 65position: middledoi
Genome of the Komodo dragon reveals adaptations in the cardiovascular and chemosensory systems of monitor lizards
Nature Ecology & Evolution 2019cited by 95position: middledoi
Tissue signals imprint ILC2 identity with anticipatory function
Nature Immunology 2018cited by 433position: middledoi
CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency
Science 2018cited by 324position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nadav Ahituv · University of California, San Francisco6 papers (2014–2018)Katherine S. Pollard · Institute for Neurodegenerative Disorders3 papers (2014–2016)David J. Erle · University of California, San Francisco3 papers (2018–2022)Rebecca E. Fisher · Allen Institute for Brain Science3 papers (2012–2018)Dale F. DeNardo · Arizona State University2 papers (2014–2018)Stephanie A. Christenson · Advanced ENT and Allergy2 papers (2021–2022)J. Alan Rawls · Arizona State University2 papers (2014–2018)Betty M. Booker · University of California, San Francisco2 papers (2016–2016)Lorna Zlock · University of California, San Francisco2 papers (2020–2022)Elizabeth Hutchins · UCLA Health2 papers (2014–2018)Julia E. VanderMeer · University of California, San Francisco2 papers (2016–2016)Luke R. Bonser · AstraZeneca (United Kingdom)2 papers (2020–2022)Mandy K. Mason · University of Cape Town2 papers (2016–2016)Kyung Duk Koh · University of California, San Francisco2 papers (2020–2022)Walter E. Finkbeiner · University of California, San Francisco2 papers (2020–2022)Nicola Illing · University of Cape Town2 papers (2016–2016)Jeanne Wilson‐Rawls · Arizona State University2 papers (2014–2018)Kenro Kusumi · University of Arizona2 papers (2012–2014)Ari B. Molofsky · San Francisco General Hospital2 papers (2018–2022)Richard M. Locksley · Howard Hughes Medical Institute2 papers (2018–2022)